Page last updated: 2024-08-17

n-vinyl-2-pyrrolidinone and Invasiveness, Neoplasm

n-vinyl-2-pyrrolidinone has been researched along with Invasiveness, Neoplasm in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hou, Z; Kong, H; Li, X; Wang, H; Xie, W; Xu, H; Zhang, H1
Abrahamsberg, C; Gschwend, JE; Horn, T; Russ, D; Straub, M1
Chin, WW; Kho, KW; Lau, WK; Lee, LS; Lim, PL; Olivo, M; Ramaswamy, B; Thong, PS1
Waidelich, R1
Engvall, E; Gombau, L; Salonen, EM; Schleef, RR1

Trials

1 trial(s) available for n-vinyl-2-pyrrolidinone and Invasiveness, Neoplasm

ArticleYear
A phase IIA dose-finding study of PVP-hypericin fluorescence cystoscopy for detection of nonmuscle-invasive bladder cancer.
    Journal of endourology, 2015, Volume: 29, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anthracenes; Cystoscopy; Dose-Response Relationship, Drug; Female; Fluorescent Dyes; Humans; Male; Middle Aged; Neoplasm Invasiveness; Perylene; Povidone; Prospective Studies; Sensitivity and Specificity; Solubility; Urinary Bladder Neoplasms

2015

Other Studies

4 other study(ies) available for n-vinyl-2-pyrrolidinone and Invasiveness, Neoplasm

ArticleYear
An efficient Trojan delivery of tetrandrine by poly(N-vinylpyrrolidone)-block-poly(ε-caprolactone) (PVP-b-PCL) nanoparticles shows enhanced apoptotic induction of lung cancer cells and inhibition of its migration and invasion.
    International journal of nanomedicine, 2014, Volume: 9

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Benzylisoquinolines; Cell Line, Tumor; Cell Movement; Diffusion; Humans; Lung Neoplasms; Nanocapsules; Neoplasm Invasiveness; Particle Size; Polyesters; Povidone; Treatment Outcome

2014
Chlorin e6-polyvinylpyrrolidone mediated photodynamic therapy--A potential bladder sparing option for high risk non-muscle invasive bladder cancer.
    Photodiagnosis and photodynamic therapy, 2010, Volume: 7, Issue:4

    Topics: Administration, Intravesical; Aged; Aged, 80 and over; BCG Vaccine; Carcinoma in Situ; Carcinoma, Transitional Cell; Chlorophyllides; Feasibility Studies; Female; Humans; Injections, Intravenous; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Photochemotherapy; Porphyrins; Povidone; Protoporphyrins; Radiation-Sensitizing Agents; Treatment Failure; Urinary Bladder Neoplasms

2010
Comment on "Chlorin e6-polyvinylpyrrolidone mediated photodynamic therapy--A potential bladder sparing option for high risk non-muscle-invasive bladder cancer" by Lui Shiong Lee et al. [Photodiagn Photodyn Ther 2010;7:213-20].
    Photodiagnosis and photodynamic therapy, 2010, Volume: 7, Issue:4

    Topics: Carcinoma in Situ; Carcinoma, Transitional Cell; Chlorophyllides; Humans; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Photochemotherapy; Porphyrins; Povidone; Protoporphyrins; Radiation-Sensitizing Agents; Urinary Bladder Neoplasms

2010
Human glioma U-251 cells contain type 1 plasminogen activator inhibitor in a rapidly releasable form.
    FEBS letters, 1996, Sep-16, Volume: 393, Issue:2-3

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Cell Fractionation; Cell Line; Centrifugation, Density Gradient; Fibrin; Fibrinolysis; Glioma; Humans; Immunohistochemistry; Neoplasm Invasiveness; Organelles; Plasminogen Activator Inhibitor 1; Povidone; Silicon Dioxide; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator

1996